Top Markets
#1 Helium Helium +61.03%
#2 Seeker Seeker +37.84%
#3 TENDIES TENDIES +27.40%
#4 Pons Pons +24.28%
#5 Zylo Ecosystem Zylo Ecosystem +21.96%
#6 Bounce Bounce +20.89%
#7 UnifAI Network UnifAI Network +20.40%
#8 Zora Zora +15.41%
#9 ZKsync ZKsync +13.35%
#10 DAPPOS DAPPOS +13.07%
Coin of the day
Helium Helium
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Poseida Therapeutics, Inc. Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc.

PSTX
Classifica tra le azioni #10560
Poseida Therapeutics, Inc., a San Diego-based clinical-stage biopharmaceutical... Poseida Therapeutics, Inc., a San Diego-based clinical-stage biopharmaceutical firm established in 2014, is dedicated to advancing novel therapeutic solutions for conditions with significant unmet medical needs. Its pipeline prominently features several advanced cell therapies. For instance, P-PSMA-101, an autologous CAR-T cell therapy, is currently undergoing Phase I clinical trials for individuals battling metastatic castrate-resistant prostate cancer (mCRPC). Additionally, Poseida is progressing two other CAR-T candidates through Phase I: P-BCMA-ALLO1 targets relapsed/refractory multiple myeloma, while P-MUC1C-ALLO1 is designed to address a variety of solid tumors, such as breast, ovarian, and other epithelial-derived malignancies. The company is further exploring allogeneic (off-the-shelf) CAR-T approaches with candidates like P-CD19CD20-ALLO1, aimed at B cell malignancies and certain autoimmune conditions, and P-BCMACD19-ALLO1, which is in preclinical development for multiple myeloma. Another allogeneic CAR-T, P-PSMA-ALLO1, is also being developed for mCRPC. Beyond cell therapies, Poseida's portfolio includes clinical-stage liver-directed gene therapies, specifically P-OTC-101 and P-FVIII-101, alongside other exploratory allogeneic dual CAR candidates. Collaborative efforts include a research and licensing agreement with Takeda Pharmaceutical Company Limited.
Prezzo delle azioni
$9.50
Ultima sincronizzazione: 2025-01-08
Capitalizzazione di mercato
$819.52M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Poseida Therapeutics, Inc. (PSTX)

Categoria

Healthcare
Il prezzo PSTX con la capitalizzazione del mercato della B
Poseida Therapeutics, Inc. Poseida Therapeutics, Inc.
PSTX
$9.50
Capitalizzazione di mercato di Poseida Therapeutics, Inc.(PSTX)
Capitalizzazione di mercato: $819.52M
A partire dal August 2026, Poseida Therapeutics, Inc. ha una capitalizzazione di mercato pari a $819.52M. Questo rende Poseida Therapeutics, Inc. la 10560th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Poseida Therapeutics, Inc. dal 2020 al 2026
PSTX in paragone con la classifica dei più popolari stocks
Il prezzo per PSTX Attivo B Capitalizzazione del mercato a B Risultati
Poseida Therapeutics, Inc. Poseida Therapeutics, Inc.
$61,019.58 $819.52M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.264T +642,211.36%
Poseida Therapeutics, Inc. Poseida Therapeutics, Inc.
$54,497.93 $819.52M
Apple Inc. Apple Inc.
AAPL
$4.701T +573,562.38%
Poseida Therapeutics, Inc. Poseida Therapeutics, Inc.
$48,422.50 $819.52M
Alphabet Inc. Alphabet Inc.
GOOG
$4.177T +509,610.51%
Poseida Therapeutics, Inc. Poseida Therapeutics, Inc.
$44,251.91 $819.52M
Microsoft Corporation Microsoft Corporation
MSFT
$3.817T +465,709.59%
Poseida Therapeutics, Inc. Poseida Therapeutics, Inc.
$33,227.03 $819.52M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.866T +349,658.16%